Trial Profile
A Phase II Study of Induction Chemotherapy Followed by Surgical Treatment in Locally Advanced Oropharyngeal And Supraglotic Cell Carcinoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Jun 2023
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Head and neck cancer; Oropharyngeal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 23 Jun 2023 Planned End Date changed from 30 Dec 2022 to 30 Dec 2023.
- 23 Jun 2023 Planned primary completion date changed from 30 Dec 2022 to 30 Dec 2023.
- 14 Nov 2022 Planned End Date changed from 30 Jun 2021 to 30 Dec 2022.